Pituitary adenylate cyclase-activating polypeptide (PACAP), a novel neuropeptide with considerable homology to vasoactive intestinal peptide and GH-releasing hormone, exists in two biologically active forms, PACAP-38 and -27. The presence of PACAP in the ovary has been demonstrated, where it stimulates steroidogenesis and cAMP accumulation in cultured granulosa cells. In the present study, gonadotropin regulation of PACAP gene expression was examined in PMSG/human (h)CG-treated immature rat ovaries and cultured preovulatory follicles. Northern blot analysis of ovaries obtained from PMSG/hCG-treated immature animals revealed the transient induction of PACAP transcripts by hCG, reaching a maximum at 6 h. The major cell types expressing PACAP messenger RNA were granulosa cells of preovulatory follicles and some theca/interstitial cells. In preovulatory follicles cultured in serum-free medium, PACAP transcripts were transiently induced by LH and FSH, reaching a maximum 6 -9 h after stimulation in granulosa cells but not in theca cells.
Treatment with cycloheximide or ␣-amanitin abolished LH-induced PACAP transcripts, indicating that new protein synthesis and transcription are necessary. Treatment with MDL-12,330A, an inhibitor of adenylate cyclase, inhibited LH-induced PACAP messenger RNA, and forskolin mimicked the LH action, implying the role of adenylate cyclase activation. In contrast, treatment with chelerythrine, an inhibitor of protein kinase C, and 2-O-tetradecanol-phorbol-13-acetate had no effect. We further tested the role of PACAP in follicle apoptosis using apoptotic DNA fragmentation analysis. Treatment with PACAP-38 suppressed follicle apoptosis in a dose-dependent manner. Moreover, the LH suppression of follicle apoptosis was partially blocked by cotreatment with PACAP-38 antagonist, indicating mediation by endogenous PACAP-38. These results suggest that PACAP, transiently induced by the gonadotropin surge, could be a local regulator of a number of events and may act as a follicle survival factor during the periovulatory period. (Endocrinology 140: 818 -826, 1999) P ITUITARY adenylate cyclase-activating polypeptide (PACAP), originally isolated from the ovine hypothalamus, exists in two biologically active amidated forms derived from a single precursor protein, PACAP-38, and a COOH-terminally truncated form, PACAP-27 (1, 2) . On the basis of sequence similarity, PACAP belongs to the secretinglucagon-vasoactive intestinal peptide (VIP) family of peptides (3) . PACAP exerts its action by binding to three types of G protein-coupled seven-transmembrane PACAP receptors: type I (PACAPR-I), which preferentially binds to PACAP (4), and type II, which shares with VIP (5). The PACAPR-I is coupled to adenylate cyclase and phospholipase C pathways, whereas type II is coupled only to the adenylate cyclase pathway (5) . It has been demonstrated that both PACAP-27 and -38 stimulate adenylate cyclase, whereas only PACAP-38 stimulates phospholipase C with high potency (6) due to the existence of splice variant in the extracellular domain of PACAPR-I (7) . A third type of receptor has recently been cloned in mice, which binds PACAP and VIP with similar affinities (8) . This third type receptor displays high-affinity helodermin (but not secretin) binding, whereas PACAPR-II binds helodermin and secretin with lower affinities than for PACAP/VIP (8) .
Studies of tissue distribution have shown that both PACAP and its receptors are present not only in the central nervous system but also in a variety of peripheral tissues, such as the testis, adrenal, and ovary (9, 10) . In the ovary, the presence of immunoreactive PACAP-38 as a predominant form has been demonstrated by RIA in whole-tissue extract in humans (11) and rats (12) . Binding sites for PACAP (13) and the presence of PACAPR-I messenger RNA (mRNA) (14) have also been demonstrated in cyclic rat ovaries. Recent studies have shown that PACAP stimulates steroidogenesis and cAMP accumulation more potently than VIP in cultured rat granulosa cells (15, 16) . Furthermore, PACAP regulates meiotic maturation, mimicking the action of LH in rat oocytes (17) , suggesting a role of PACAP in the regulation of ovarian function as a new local factor. Of relevance to the present work, it has been shown that PACAP mRNA is found primarily in granulosa cells of preovulatory follicles and some theca/interstitial cells and regulated in vivo by gonadotropins in the rat ovary (18) .
In the present study, we elucidated more detailed time-dependent induction of PACAP mRNA by gonadotropins both in ovaries of PMSG/human (h)CG-treated immature rats and in cultured preovulatory follicles. We found that gonadotropins could induce a transient expression of PACAP transcripts, which was maximal at 6 h after stimulation in granulosa cells of preovulatory follicles, possibly by activating adenylate cyclase. We also demonstrated the role of PACAP in the suppression of follicle apoptosis.
Materials and Methods

Hormones and reagents
Ovine LH (LH-S-26; 2,300 IU/mg) and purified pituitary hFSH (I-SIAFP-1; 8,466 IU/mg) were obtained from the National Hormone and Pituitary Distribution Program, NIDDK, NIH (Baltimore, MD). hCG, PMSG, cycloheximide, ␣-amanitin, forskolin, and 2-O-tetradecanolphorbol-13-acetate (TPA) were purchased from Sigma Chemical Co. (St. Louis, MO). PACAP-38 and PACAP , an antagonist of PACAP-38, were obtained from Bachem (Torrance, CA). MDL-12,330A and chelerythrine (CE) chloride were purchased from Calbiochem (San Diego, CA). The progesterone antiserum was donated by Dr. Yong-Dal Yoon (Hanyang University, Seoul, Korea).
Animals
Immature (26-day-old; BW, 60 -65 g) female Sprague Dawley rats (Daehan Laboratories, Chungbuk, Korea) were injected sc with 10 IU PMSG to induce multiple follicle growth. At 48 -52 h later, the animals were killed by cervical dislocation, and the ovaries were removed for follicle dissection. In pilot experiments, these rats responded optimally to an ovulatory dose (10 IU) of hCG at 2 days after 10-IU PMSG treatment, based on their ovulation rate (34.4 Ϯ 5.5 ova per rat; n ϭ 9). Some rats received a single ip injection of 10 IU hCG to induce ovulation, and ovaries were obtained at different time intervals for Northern blot and in situ hybridization analysis.
Follicle culture
Preovulatory follicles (Ͼ800 m in diameter) were isolated from ovaries collected at 48 -52 h after PMSG injection, and follicle culture was performed as previously described (19, 20) . For follicle apoptosis studies, two follicles were cultured in glass vials containing 400 l Eagle's MEM (Gibco, Grand Island, NY) supplemented with penicillin, streptomycin, l-glutamine, and 0.1% BSA (wt/vol, Fraction V, Sigma Chemical Co., St. Loius, MO) in the absence or presence of different hormones. In some cultures, fifteen to twenty follicles were incubated in 800 l of medium for studies of PACAP mRNA expression. Cultures were maintained for up to 24 h at 37 C under 5% CO 2 -95% O 2 . At the end of incubation, follicles were snap-frozen for DNA and RNA isolation or were fixed for in situ hybridization analysis. The media were collected for the determination of progesterone levels by RIA.
Northern blot analysis
Total RNA from ovaries or cultured follicles was isolated using Tri Reagent solution (Molecular Research Center, Inc., Cincinnati, OH). Twenty micrograms of total RNA were fractionated by electrophoresis on a 1.2% agarose gel containing formaldehyde and were transferred to nylon membranes by capillary blotting with 20 ϫ sodium citrate-sodium chloride (SSC). After a UV cross-linking and prehybridization, membranes were hybridized overnight at 65 C in a solution containing 50% formamide, 5 ϫ SSC, 1.6 ϫ Denhardt's solution, 1 mm EDTA, 250 g/ml denatured herring sperm DNA, 500 g/ml yeast transfer RNA, and a total of 2-4 ϫ 10 6 cpm of a 32 P-labeled rat PACAP complementary DNA (cDNA) probe (21) . After hybridization, membranes were washed twice for 5 min at room temperature in 2 ϫ SSC and 0.1% SDS, followed by 1 h at 65 C in 0.5 ϫ SSC and 0.1% SDS. Membranes were then exposed using Kodak RX films (Eastman Kodak Co., Rochester, NY) for 2-5 days for ovarian samples and for 2-12 h for cultured follicular samples at Ϫ80 C. For normalization of data, blots were stripped by boiling in 0.1 ϫ SSC and 0.5% SDS twice for 20 min before reprobing with a cDNA probe for rat glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) (22) .
In situ hybridization analysis
Ovaries or cultured follicles were fixed at 4 C for 6 h in 4% paraformaldehyde in PBS, followed by immersion in 0.5 m sucrose in PBS overnight. Cryostat sections (14-m thick) were mounted on poly-llysine (Sigma Chemical Co.)-coated microscope slides, fixed in 4% paraformaldehyde in PBS, and stored at Ϫ80 C until analyzed. The hybridization procedure was essentially the same as previously described (23) . In brief, sections were pretreated serially with 0.2 m HCl, 2 ϫ SSC, pronase (0.125 mg/ml), 4% paraformaldehyde, and acetic anhydride in triethanolamine. Hybridization was carried out at 52-55 C overnight in the mixture containing 35 S-labeled rat PACAP cRNA probe (10 8 cpm/ ml), 50% formamide, 0.3 m NaCl, 10 mm Tris-HCl, 5 mm EDTA, 1 ϫ Denhardt's solution, 10% dextran sulfate, 1 g/ml carrier transfer RNA, and 10 mm dithiothreitol. Posthybridization washing was performed under stringent conditions that included ribonuclease A (25 g/ml) treatment at 37 C for 30 min and a final stringency of 0.1 ϫ SSC. Slides were dipped into NTB-2 emulsion (Eastman Kodak Co.) and exposed at 4 C until being developed after 2 weeks. The slides were stained with hematoxylin and eosin and were examined under the light microscope with bright-and dark-field illumination.
DNA fragmentation analysis
Cellular DNA was extracted from follicles and analyzed as previously described (20, 24) . Aliquots of 0.5 g DNA from each culture were labeled at 3Ј-ends with gels. Gels were dried in a slab gel dryer and exposed using Kodak x-ray films (Eastman Kodak Co.) at Ϫ80 251 C. After autoradiography, portions of each lane corresponding to DNA less than 15 kb (kb) were isolated and counted in a ␤-counter for quantitation of the degree of apoptotic DNA fragmentation. All data are expressed as per cent of the control group at 24 h of culture.
RIA
Concentrations of progesterone in culture media were determined by RIA, as previously described (25) , and expressed as ng/ml.
Data analysis
Statistical differences were assessed by one-way ANOVA, followed by Student's t test; and P Ͻ 0.05 was considered significant.
Results
Expression of PACAP mRNA in hCG-treated ovaries
Northern blot analysis of total ovarian RNA obtained from PMSG-primed/hCG-treated rats revealed three bands hybridizing with rat PACAP cDNA (Fig. 1) . The levels of mRNA were transiently induced by hCG administration, reaching a maximum induction 6 h after hCG treatment. The most intense band had a size of 1.2 kb. The 2.4-and 3.0-kb bands corresponded in size to those observed in the hypothalamus. PACAP specific bands were not detected at any time points in postnatal, estrogen-treated, or PMSG-primed ovaries (data not shown).
To characterize the cell types expressing PACAP mRNA in hormone-stimulated ovaries, antisense and sense cRNA probes for rat PACAP were generated for in situ hybridization analysis. In the ovaries of PMSG/hCG-stimulated immature rats, high levels of PACAP transcripts were detected in the granulosa cells of preovulatory follicles (Fig. 2, B and E), but not growing follicles (Fig. 2, B and H) . Under higher magnification, it was observed that the parietal granulosa cells expressed higher levels of PACAP mRNA than the expanded mature cumulus cells (Fig. 2F) . Specific signals for PACAP transcripts were also detected in a few scattered solitary interstitial cells and in some theca cells, regardless of follicle size ( Fig.  2 ; B, H, and I). Adjacent sections hybridized with the sense cRNA probe did not show any hybridization signal (Fig. 2C) . Specific signals were not detected at any time points in PMSGor estrogen-treated ovaries (data not shown).
Gonadotropin stimulation of PACAP mRNA in cultured preovulatory follicles
To study the hormonal regulation of PACAP mRNA expression, preovulatory follicles obtained from ovaries of rats primed for 2 days with PMSG were incubated in serum-free condition. Northern blot analysis revealed that gonadotropin treatment resulted in a transient induction of PACAP mRNA (Fig. 3) . The effect of LH on PACAP mRNA stimulation delayed, relative to that of FSH; levels of PACAP transcripts remained elevated at 12 h after LH treatment (Fig. 3A) , whereas they were barely detectable after FSH treatment (Fig. 3B) . PACAP transcripts were not detectable in follicles before culture and 24 h after gonadotropin addition. As shown in Fig. 4 , both LH and FSH treatment for 6 h induced PACAP mRNA in a dose-responsive manner, reaching saturating levels at 100 ng/ml.
To determine the site of PACAP mRNA expression in cultured preovulatory follicles, in situ hybridization was performed on sections of follicles incubated in the presence of LH for 6 h. High levels of PACAP mRNA were concentrated in granulosa cells (Fig. 5) . The parietal granulosa cells had higher signals than the expanded cumulus cells (Fig. 5C) , comparable with the expression seen in vivo 6 h after hCG administration (Fig. 2F) . However, theca cells were devoid of specific signals (Fig. 5C) . No specific signal was detected in follicles hybridized with sense probe (Fig. 5D) .
Effects of cycloheximide and ␣-amanitin on LH-induced PACAP mRNA in cultured preovulatory follicles
To determine whether new protein synthesis or transcription is necessary for the induction of PACAP mRNA by LH, preovulatory follicles were incubated in the presence of both LH and increasing doses of cycloheximide or ␣-amanitin. The protein synthesis inhibitor, cycloheximide, blocked the LH induction of PACAP transcripts in a dose-dependent manner, a marked decrease at 1 g/ml (Fig. 6A) . Inclusion of ␣-amanitin, an inhibitor of transcription, also blocked the LH induction of PACAP transcripts, with a complete abolishment at 25 g/ml (Fig. 6B) . Treatment of follicles with cycloheximide or ␣-amanitin alone had no effect.
LH induces PACAP mRNA by activating adenylate cyclase in cultured preovulatory follicles
In addition to the stimulation of the adenylate cyclasecAMP pathway, the actions of LH are additionally mediated by other intracellular messengers, such as those derived from the phospholipase C pathway (26) . To determine the signaling pathway for PACAP mRNA induction by LH, preovulatory follicles were incubated for 6 h in the presence of 10 m MDL, an inhibitor of adenylate cyclase, or 10 m CE, an inhibitor of protein kinase C, with or without LH (200 ng/ ml). Some follicles were treated with 10 m forskolin or 200 nm TPA alone for 6 h. Inclusion of MDL markedly decreased LH-induced PACAP transcripts (Fig. 7) . In contrast, the addition of CE did not affect the LH action on stimulation of PACAP mRNA. Moreover, forskolin treatment stimulated the induction of PACAP transcripts, whereas treatment with the phorbol ester TPA had no effect. Follicles incubated with MDL or CE alone did not show any PACAP transcripts.
Effect of PACAP on apoptosis and steroid production in cultured preovulatory follicles
To evaluate the role of PACAP in follicle apoptosis, preovulatory follicles were cultured in serum-free medium for 24 h in the presence of LH or increasing doses of PACAP-38 (10 -9 -10 -6 m). As reported previously (20) , follicles cultured for 24 h without hormones showed the extensive apoptosis, and LH treatment markedly suppressed it (Fig. 8A) . Incubation of follicles with PACAP-38 caused a dose-related reduction in the extent of apoptotic DNA cleavage (52.2% of 24-h controls at 10 -6 m). Furthermore, cotreatment with PACAP-38 specific antagonist (P38-A) prevented the suppressive effect of PACAP-38. Because LH increased PACAP transcript levels in preovulatory follicles (Fig. 3) , we determined whether the suppressive effect of LH on follicle apoptosis is mediated via the action of endogenous PACAP. As shown in Fig. 8B , LH-induced suppression of follicle apoptosis was partially inhibited (47.1%) by cotreatment with PACAP-38 antagonist (10 -5 m). Treatment with PACAP-38 antagonist alone had no effect on follicle apoptosis.
Because PACAP is known to stimulate steroid production in cultured granulosa cells of estrogen-treated ovaries (15, 16) , we further tested progesterone production by preovulatory follicles during the 24 h of culture with PACAP-38. As shown in Fig. 9 , levels of progesterone were increased by LH (8-fold). Treatment with PACAP-38 caused a dose-dependent increase in progesterone production (4-fold at 10 -6 m), and this increase was partially inhibited by the addition of PACAP-38 antagonist (10 -5 m).
Discussion
We have established an in vitro follicle culture model to study the hormonal regulation and signaling pathway of PACAP gene expression in the rat ovary. The present study demonstrates that gonadotropins cause the transient induction of PACAP mRNA in granulosa cells of preovulatory follicles and that this gonadotropin action requires new protein synthesis and transcription and the activation of ade- nylate cyclase. We have also demonstrated that gonadotropin-induced PACAP suppresses follicle apoptosis and stimulates progesterone production by preovulatory follicles.
Although immunoreactive PACAP, mainly in the form of PACAP-38, has been reported to be present in the ovary (11, 12) , it has only recently been demonstrated by Gräs et al. (18) that gonadotropins can induce a transient expression of PACAP mRNA in the rat ovary. In that report, hCG administration to PMSG-primed immature rats stimulated PACAP mRNA expression in granulosa cells of preovulatory follicles and in some theca/interstitial cells, with a maximum induction around 12 h after stimulation; whereas PMSG administration stimulated PACAP mRNA expression only in some theca/interstitial cells (18) . In the present study, however, PMSG administration to immature rats was unable to stimulate PACAP mRNA expression at any time points examined by Northern blot and in situ hybridization analysis (data not shown). Furthermore, hCG injection induced a transient expression of PACAP mRNA, reaching a maximum at 6 h and being barely detectable at 12 h after stimulation. At present, we cannot explain the reason for the difference in PMSG effect and timing of hCG-induced PACAP mRNA induction between our present findings and work of Gräs et al. It may be because of the difference in hormone responsiveness derived from the difference in maturity of the test animals (26-day-old Sprague Dawley vs. 20-to 23-day-old Wistar rats).
To study the mechanism of stimulatory action of gonadotropins on PACAP mRNA expression, we have employed in vitro culture of preovulatory follicles obtained from PMSG-primed rats. Treatment with exogenous LH or FSH in cultured follicles could induce a transient expression of PACAP mRNA in a dose-dependent manner, mimicking the expression pattern of PACAP mRNA after hCG injection in vivo. Northern blot analysis revealed three different PACAP transcripts. One transcript, 1.2 kb in size, has been reported to be expressed in the rat testis (27) . The other two transcripts (2.4 and 3.0 kb in size) were similar to those observed in nervous tissue (28) . The major cell type expressing PACAP mRNA in cultured preovulatory follicles was granulosa cells. However, unlike in vivo hCG-treated ovaries, theca cells were devoid of PACAP-specific signal in response to LH. Furthermore, PACAP mRNA remained elevated for up to 12 h in preovulatory follicles cultured in vitro with LH, compared with ovaries treated with hCG in vivo, indicating that the mechanism mediating the rapid decline in PACAP mRNA after hCG treatment in vivo is reduced in vitro after LH treatment. A similar observation has been reported in the induction of PG endoperoxide synthase (29) . Accordingly, one possible explanation for the difference is that cAMP production seems to be sustained longer in vitro after LH treatment (30) .
It has been indicated that low concentrations of LH preferentially activate adenylyl cyclase, whereas higher concentrations of the hormone also increase intracellular calcium and activate protein kinase C (PKC) (31, 32) . The present findings, showing the inhibition of LH action on the induction of PACAP mRNA by adenylyl cyclase inhibitor, but not by PKC inhibitor, provide evidence to hypothesize a primary role for cAMP in PACAP mRNA expression in preovulatory follicles. Indeed, it has been reported that the 5Ј flanking region of the hPACAP gene contains sequence motif homologous to cAMP response element (33) . Furthermore, the induction of PACAP mRNA by LH in vitro was blocked by either cycloheximide or ␣-amanitin, indicating that translational and transcriptional events are involved in cAMP-mediated induction of PACAP mRNA. Similar observations have been reported in the transient appearance of progesterone receptor (34) and PG endoperoxide synthase mRNAs (29) in preovulatory follicles after LH/hCG stimulation.
The preovulatory surge of gonadotropins is obligatory, to trigger the ovulatory process (including follicle rupture, oocyte maturation, and luteinization) (35) . The mature follicles not exposed to the ovulatory signal undergo apoptotic degeneration (36, 37) , and recent studies demonstrate that insulin-like growth factors I and Il-1␤ play a role in mediating the gonadotropic action on the suppression of follicle apoptosis (19, 20) . Thus, our observation, showing the transient stimulation of PACAP mRNA during LH/hCG-induced ovulation, prompted us to examine the role of PACAP in follicle apoptosis. The present study demonstrated that treatment with PACAP-38 dose-dependently suppresses apoptotic DNA fragmentation in the follicles, indicating that PACAP-38 is capable of protecting preovulatory follicles from apoptotic death. Furthermore, the suppressive effect of LH was partially reversed by the addition of PACAP-38 antagonist, suggesting that part of the action of LH is also mediated by endogenously produced PACAP-38. PACAP-38 has been shown to inhibit apoptosis in neuronal cells by activating the mitogen-activated protein kinase through a cAMP-dependent pathway (38) . Because PACAP is known to stimulate cAMP accumulation in ovarian granulosa cells (15) and the suppression of follicle apoptosis is mediated by cAMP pathway (39), PACAP-38 might inhibit preovulatory follicle apoptosis by increasing cAMP levels in granulosa cells.
PACAP can interact with specific receptors. The type I receptor binds preferentially to PACAP, and the type II binds PACAP and VIP with similar affinity (3). The present observation, demonstrating a dose-dependent increase in progesterone production by PACAP-38, implicates the presence of PACAP receptors in preovulatory follicles. Indeed, PACAP has been shown to be more potent than VIP in the stimulation of cAMP and steroidogenesis in cultured granulosa cells from estrogen-treated immature rats (15, 16) , suggesting the presence of PACAP type I receptor. In a recent study, PACAP has been shown to accelerate oocyte maturation in follicle-enclosed, cumulus-enclosed, and denuded oocytes, whereas VIP is effective only in follicle-enclosed oocytes (17) . The data from that study imply that different subtypes of PACAP receptors are present in the different ovarian compartments.
The LH surge is known to induce expression of several genes associated with follicle rupture and luteinization (40) . The rapid, but transient, expression of the progesterone receptor (34), tissue plasminogen activator (41), Il-1␤ (42) , and PG endoperoxide synthase (29) genes seems to be temporally and functionally associated with the process of follicle rupture. In contrast, the biochemical changes that are associated with luteinization include the sustained induction of P450scc (43), the transient increase in progesterone receptor (34), aromatase (44) , and 17␣-hydroxylase (45) . Whether the dramatic and transient expression of PACAP, after LH/hCG treatment, plays a critical role in the ovulatory process remains to be elucidated.
In summary, gonadotropin induction of PACAP mRNA in granulosa cells of preovulatory follicles is mediated by cAMP, involving translational and transcriptional controls. The transient appearance of PACAP plays a role in the suppression of follicle apoptosis and may involve novel intracellular factors and the regulatory processes during the periovulatory period.
